Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Frequently asked questions
What sector does Microbot Medical Inc (CY9D) operate in?
Microbot Medical Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Microbot Medical Inc (CY9D) current stock price?
As of the latest data, Microbot Medical Inc stock price is €0.83, with a previous close of €0.91. Microbot Medical Inc lost -€0.08 in the last trading session, representing a -8.83% loss.
What is Microbot Medical Inc (CY9D) current market capitalization?
Microbot Medical Inc market cap is approximately 55.48 million.
What is Microbot Medical Inc (CY9D) Earnings Per Share (EPS)?
The trailing EPS is -€0.21.
Does Microbot Medical Inc (CY9D) pay dividends?
No. Microbot Medical Inc does not pay a dividend.
What is Microbot Medical Inc (CY9D) beta (volatility) score?
Microbot Medical Inc has a beta of 1.046, meaning its volatility is roughly in line with the market.
